Delivery Order SPE2DB22D1106-SPE2DB24FFMC8

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the provision of Trulicity 3 mg/0.5 ml pens. The fixed-price contract has a ceiling value of $8,998.68 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $1,161.12 and a period of performance through August 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to efficiently procure a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens with a 0.5 ml dosage. It is a firm-fixed-price delivery order with a ceiling value of $1,456.07 and an ultimate completion date of May 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order has a ceiling value of $22,403.12 and runs through February 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC enables efficient...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $1,338.75 firm fixed-price Delivery Order contract for the supply of Trulicity 1.5 mg/0.5 ml pens. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, valued at $5,673.54, is a delivery order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the medication Trulicity 1.5 mg/0.5 ml pen to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,545.26 and is a firm fixed price delivery order. The contract has an ultimate completion date of August 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $5,130.55. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens and has a completion date of February 19, 2025. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a $3,350.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $10,643.01 and an ultimate completion date of February 20, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFMC8
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $14,127.46 and an ultimate completion date of September 11, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/10/24, 2:18 PM